<DOC>
	<DOCNO>NCT01104272</DOCNO>
	<brief_summary>The device delivers High Intensity Focused Ultrasound ( HIFU ) energy disrupt subcutaneous adipose tissue ( SAT ) provide non-invasive approach body sculpt , reduction waist circumference .</brief_summary>
	<brief_title>Subcutaneous Contouring Using High Intensity Focused Ultrasound</brief_title>
	<detailed_description />
	<criteria>All following inclusion criterion must meet time screen subject enrol study : 1 . Male female subject , 18 65 year age 2 . Body Mass Index ≤30 3 . Thickness subcutaneous adipose tissue anticipate treatment area ≥ 2.5 cm 4 . Subjects must agree alter normal regular diet exercise routine course study . 5 . Subjects must African descent AND Fitzpatrick skin type IV , V , VI . A subject ineligible participate study meet follow exclusion criterion screen : 1 . Female subject pregnant ( i.e. , positive urine pregnancy test ) , suspect pregnant , lactate becomes pregnant course study . ( NOTE : Females childbearing potential must negative urine pregnancy test prior enrollment study . ) 2 . Subjects diagnosed coagulation disorder receive anticoagulant therapy medication dietary supplement impede coagulation platelet aggregation . 3 . Subject diabetes cardiovascular disease . 4 . Subject aesthetic procedure region treat . 5 . Subject systemic skin disease skin disease area treat . 6 . Subject abnormality skin soft tissue abdominal wall area treat . 7 . Subject previous open laparoscopic surgery anticipate treatment area . 8 . Subjects prescription counter weight reduction medication program , weight reduction procedure ( e.g . : gastric bypass , LapBand , etc . ) 9 . Subject skin superficial tissue lie flat subject supine position . 10 . Subjects undergo chronic steroid immunosuppressive therapy . 11 . Subjects cardiac pacemaker implantable electrical device , e.g . pacemaker , defibrillator , neurostimulators . 12 . Subjects metal implant type area treat . 13 . History cancer . 14 . Subjects sensory loss dysesthesia area treat . 15 . Subject currently use illicit drug ( ) abuse alcohol ( defined regular daily consumption 4 alcoholic drink per day ) . 16 . Subjects adhere study visit schedule ( e.g. , subject likely stay study maximum 27 week screen exit visit ) . 17 . Subjects unable , lack capacity , self consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Ultrasound Treatment Subcutaneous Adipose Tissue</keyword>
</DOC>